lobbying_activities: 1125089
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1125089 | 357a9104-20ff-46f3-a31c-b230c0aff68a | Q2 | GEPHARDT GROUP GOVERNMENT AFFAIRS | 315717 | HEALIANCE PHARMACEUTICALS | 2011 | second_quarter | PHA | innovative diabetes treatment | HOUSE OF REPRESENTATIVES,Natl Security Council (NSC),SENATE,State, Dept of (DOS),Treasury, Dept of | 20000 | 0 | 0 | 2011-07-19T17:12:50.803000-04:00 |